UNITY Biotechnology (UBX) to Offer $25M in Common Stock

Go back to UNITY Biotechnology (UBX) to Offer $25M in Common Stock

UNITY Biotechnology Announces Proposed Public Offering of Common Stock

August 16, 2022 4:01 PM UTC

SOUTH SAN FRANCISCO, Calif., Aug. 16, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) (Nasdaq: UBX), a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that it has commenced a proposed underwritten public offering of $25.0 million of shares of its common stock. In addition, UNITY expects to grant the underwriters of the offering a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering at the public offering price, less underwriting discounts and commissions. All of the... More